IL7R and infection: To assess this, at day 5 after MAb treatment (day 9 after infection), we profiled Db-NS4B-tetramer+ CD8+ T cells for expression of PD-1, CTLA-4, CD43, CD44, CD127, and CD11a (Figure 7A).